Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL

Blood

Volumn 119, Issue 16, 2012, Pages 3864-3866

  De Keersmaecker, Kim ^a   Michaux, Lucienne ^a   Bosly, André ^b   Graux, Carlos ^b   Ferreiro, Julio Finalet ^a   Vandenberghe, Peter ^a   Cools, Jan ^a   Wlodarska, Iwona ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH1 RECEPTOR; PROTEIN BCL 3;

ADULT; BLOOD; BONE MARROW; CASE REPORT; CELL LYSATE; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LETTER; LYMPH NODE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84860328938     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-388124     Document Type: Letter

References (10)

1. Fabbri G, Rasi S, Rossi D et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med. 2011; 208(7):1389-1401.
2. Puente XS, Pinyol M, Quesada V et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011;475(7354): 101-105.
3. Rossi D, Rasi S, Fabbri G et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood. 2012;19(2):521-529.
4. Weng AP, Ferrando AA, Lee W et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306(5694):269-271. (Pubitemid 39336870)
5. Sportoletti P, Baldoni S, Cavalli L et al. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. Br J Haematol. 2010;151(4):404-406.
6. Rossi D, Spina V, Deambrogi C et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood. 2011; 117(12):3391-3401.
7. Martinez A, Pittaluga S, Villamor N et al. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol. 2004;28(7):849-858. (Pubitemid 38856839)
8. Michaux L, Dierlamm J, Wlodarska I et al. t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. Cancer Genet Cytogenet. 1997;94(1):36-43. (Pubitemid 27133499)
9. Soma LA, Gollin SM, Remstein ED et al. Splenic small B-cell lymphoma with IGH/BCL3 translocation. Hum Pathol. 2006;37(2):218-230. (Pubitemid 43099843)
10. Huh YO, Abruzzo LV, Rassidakis GZ et al. The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases. Br J Haematol. 2007;136(2):220-228. (Pubitemid 46020749)